LOS ALTOS overnight.
RenovoRx announced acceptance for publication in an international peer-reviewed journal, The Oncologist. The manuscript is titled, “Treatment of Locally Advanced Pancreatic Cancer (LAPC) Using Localized Trans-Arterial Micro Perfusion (TAMP™) of Gemcitabine: Combined Analysis of RR1 and RR2” and expected in the Summer 2024 issue of The Oncologist.
End.
IMU, in collaboration with Renovo is waiting in line for its turn, not a matter of if but when.
RNXT up on the announcement.
IMO & pure speculation.
Media Thread, page-14587
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.0¢ |
Change
-0.001(1.96%) |
Mkt cap ! $367.4M | |||
| Open | High | Low | Value | Volume |
| 5.1¢ | 5.2¢ | 4.9¢ | $896.1K | 17.89M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 39 | 5978561 | 4.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.0¢ | 299041 | 4 |
View Market Depth
| Last trade - 16.10pm 08/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |